Donna R. Cryer, JD
Donna R. Cryer, JD, is the founder and chief executive officer of the Global Liver Institute (GLI), the only patient-driven liver health nonprofit operating in the US and Europe. She has channeled her personal experience as a patient with inflammatory bowel disease and a 25-year liver transplant recipient into professional advocacy across a career in law, policy, consulting, public relations, clinical trial recruitment, and nonprofit management. Donna is a graduate of Harvard-Radcliffe Colleges and Georgetown University Law Center.
GLI convenes the NASH Council, Liver Cancers Council, International NASH Day, and the Advanced Advocacy Academy, equipping liver patients to be effective advocates. www.globalliver.org and on Twitter @globalliver
Articles
An Important Step Toward Increasing the 5-Year Survival Rate of Liver Cancer Patients
Unlike many other cancer rates that have been on the decline, liver cancer rates for new liver and intrahepatic bile duct cancer cases have been rising. This October, which is Liver Cancer Awareness Month, Global Liver Institute is joining with more than 30 other leading health and medical organizations, to issue a global call-to-action to increase the 5-year survival rates for patients with liver cancer from 18% to 36% by 2030.
